Use of VEGF inhibitors for treatment of eye disorders
US7306799B2 · kind B2 · utility
97Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 25, 2005 |
| Grant date | Dec 11, 2007 |
| Priority date | — |
| Expiry date | Jan 4, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modified chimeric polypeptides with improved pharmacokinetics and improved tissue penetration are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.